MedTrace Logo

Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment

NCT00737724 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2015-03-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate and compare the efficacy of immediate antiretroviral therapy versus 2 month deferred anti-Tb therapy upon the clinical course of tuberculosis and HIV infection in patients with AIDS and active tuberculosis.

Conditions

Interventions

DRUG

Simultaneous ARV and antiMTB

Receives both, simultaneously antiretroviral therapy and antituberculosis therapy

DRUG

Deferred RV and antiMTB treatment

Receives only antituberculosis therapy and 2 months afterwards antiretroviral therapy

Sponsors & Collaborators

  • Consorcio de Investigación sobre VIH/SIDA/TB (CISIDAT).

    collaborator OTHER

  • Instituto Nacional de Enfermedades Respiratorias

    lead OTHER_GOV

Principal Investigators

  • Gustavo Reyes-Terán, MD · Instituto Nacional de Enfermedades Respiratorias

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00737724 on ClinicalTrials.gov